NRX Pharmaceuticals, Inc. Common Stock
$3.35
-$0.05 (-1.47%)
$3.32Day Range$3.45
Key Statistics
Market Cap
$145.04M
Shares Outstanding
43.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 25, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$3.39
Day High
$3.45
Day Low
$3.32
Volume
716.0K
VWAP
$3.38
Prev Close
$3.40
Transactions
--
Acc. Volume
--
About NRX Pharmaceuticals, Inc. Common Stock
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
PHARMACEUTICAL PREPARATIONSSIC 283429 employees1201 ORANGE STREET, WILMINGTON, DE, 19801484-254-6134IPO May 25, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001719406
- Composite FIGI
- BBG00JCWDN63
- Share Class FIGI
- BBG00JCWDNX3
- Ticker Root
- NRXP
- SIC Code
- 2834
About NRX Pharmaceuticals, Inc. Common Stock (NRXP) Stock
NRX Pharmaceuticals, Inc. Common Stock (NRXP) closed the 2026-09-16 session at $3.35, down 1.47% versus the previous close (-0.05). The stock opened at $3.39 and traded between $3.32 and $3.45 during that session. Session trading volume was 716K shares. The volume-weighted average price (VWAP) is $3.38.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
NRX Pharmaceuticals, Inc. Common Stock has a market capitalization of $145.0 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. NRXP is listed on the XNAS exchange. The company employs approximately 29 people. NRX Pharmaceuticals, Inc. Common Stock is headquartered in WILMINGTON, DE. The recorded listing date is 2021-05-25.
On this page you can find market NRXP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.